Ultragenyx Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
18.02.26
/
50%
€17.40
Target price
18.02.27
€66.69
Performance (%)
72.24%
Price
09.07.26
€30.33
Summary
This prediction is currently active. With a performance of 72.24% the BUY prediction by Canaccord_Genuity_Gr is a big success. This prediction currently runs until 18.02.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 3.368% | 3.368% |
| iShares Core DAX® | -1.779% | 2.475% |
| iShares Nasdaq 100 | 1.522% | 3.290% |
| iShares Nikkei 225® | 1.083% | 7.039% |
| iShares S&P 500 | 0.929% | 3.254% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $128.00 to $79.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat